POINT Biopharma Global Inc

PNT · NASDAQ

Pharmaceutical Preparation Manufacturing

POINT Biopharma Global Inc. is a globally focused radiopharmaceutical company building a platform for the clinical development and commercialization of radioligands that fight cancer. POINT Biopharma Global Inc. is combining a portfolio of best-in-class radiopharmaceutical assets, a seasoned management team, expertise in radioisotopes such as Actinium-225 (Ac-225) and Lutetium-177 (Lu-177), and industry-leading manufacturing capabilities and supply chain to revolutionize theragnostic drug development and radioligand commercialization.

ESG Scores

Overall ESG

6.4

Environmental

6.6

Social

3.7

Governance

6.6

Public ESG Grades

Overall: BB (Medium)

E: BBS: BG: B

Gender Diversity

Female Directors0.125%

Female Executives0.2%

CEO GenderMale